Delivery Order #SPE2DR26FKKW8

Delivery Order for Xolair Autoinjectors Under IDV by DMS Pharmaceutical Group

This award is a delivery order under a previously established Indefinite Delivery Vehicle (IDV) contract to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical and medical supply services. The contract procures Xolair 300 MG/2 ML autoinjectors, a critical medication used for treatment in health care settings, highlighting its importance in maintaining uninterrupted access to essential pharmaceuticals. The scope covers the supply and delivery of these autoinjectors to a specific location within a short, defined timeframe in early 2026. This delivery order follows the competitive IDV contract known as Pharmaceutical PV Division - FSB, which ensures continued access to vital drugs. The award is part of a strategic effort to sustain public health initiatives by providing necessary medications on time. The timeline for this contract spans a focused delivery period of a few weeks, enabling prompt fulfillment of healthcare needs.

Description

4571128553!XOLAIR 300 MG/2 ML AUTOINJECT 2ML

View original record